How should I interpret a PHQ‑4 (Patient Health Questionnaire‑4) total score and what are the recommended next steps based on the score?

PHQ-4 Interpretation and Next Steps

The PHQ-4 is an ultra-brief 4-item screening tool that combines depression (PHQ-2) and anxiety (GAD-2) assessment, with a total score ranging from 0-12; scores ≥6 indicate clinically significant psychological distress requiring further evaluation, while scores of 3-5 suggest mild symptoms warranting monitoring. 1

Score Interpretation

The PHQ-4 uses a straightforward scoring system where each item is rated 0-3 based on symptom frequency over the past 2 weeks:

• 0-2: Minimal symptoms - no action needed
• 3-5: Mild symptoms - monitor and reassess
• 6-12: Moderate to severe symptoms - requires further evaluation 1, 2

The instrument demonstrates strong psychometric properties with internal consistency (Cronbach's α = 0.85 for total scale) and explains 84% of total variance across two discrete factors: depression and anxiety 1, 3.

Subscale Analysis

You can separately evaluate the two 2-item components:

PHQ-2 (Depression subscale - items 1-2):

• Score ≥3 suggests clinically significant depressive symptoms 2

GAD-2 (Anxiety subscale - items 3-4):

• Score ≥3 suggests clinically significant anxiety symptoms 2

This separation is clinically valuable because anxiety has substantial independent effects on functional status beyond depression alone 1.

Clinical Action Algorithm

For scores 0-2 (Minimal):

• No further screening required
• Routine follow-up at standard intervals

For scores 3-5 (Mild):

• Reassess in 2-4 weeks
• Address modifiable stressors
• Provide psychoeducation about symptoms
• Monitor for progression

For scores ≥6 (Moderate to Severe):

• Immediate action required: Administer full PHQ-9 for depression and GAD-7 for anxiety to establish severity and guide treatment 4
• Assess for suicidal ideation or self-harm risk
• Evaluate functional impairment in work, home, and social domains
• Rule out medical causes (pain, fatigue, delirium, medication effects, substance use) 4

If suicidal ideation or risk of harm to self/others is present:

• Refer immediately for emergency psychiatric evaluation
• Facilitate safe environment with one-to-one observation
• Initiate harm-reduction interventions 4

Treatment Pathways Based on Full Assessment

After completing PHQ-9 (if PHQ-4 ≥6), stratify by severity:

PHQ-9 scores 1-7 (Minimal/Mild):

• Watchful waiting with biweekly reassessment
• Address coping skills and social support
• No formal treatment needed unless functional impairment present 4

PHQ-9 scores 8-14 (Moderate):

• Low-intensity interventions: self-guided CBT, behavioral activation, group-based CBT, structured exercise programs
• Consider pharmacotherapy if functional impairment is moderate
• Seek consultation with psychology/psychiatry for diagnostic clarification 4

PHQ-9 scores 15-27 (Moderate-Severe to Severe):

• Mandatory referral to psychiatry/psychology for diagnosis and treatment
• High-intensity interventions: individual psychotherapy (CBT, behavioral activation), pharmacotherapy with antidepressants
• Monitor biweekly until symptom remission 4

Important Clinical Caveats

Population-Specific Considerations:

• The PHQ-4 shows measurement invariance across gender, age, nativity, and language, making it broadly applicable 5
• However, female athletes and team sport members score significantly higher, so interpret in clinical context 6
• The commonly cited cutoff of ≥6 may be too high in certain populations (e.g., patients with intracranial tumors), where a cutoff of 2.5 showed better sensitivity (76.8-82.5%) 7

Monitoring and Follow-Up:

• The PHQ-4 is valid for longitudinal monitoring with weekly or biweekly administration 6
• Expect significant floor effects (54% of scores may be zero in non-distressed populations) 6
• Reassess every 2-4 weeks until symptoms remit
• After 8 weeks of treatment without improvement despite good compliance, alter the treatment course 4

Correlation with Functional Impairment:

• Increasing PHQ-4 scores strongly correlate with functional impairment, disability days, and healthcare utilization 1
• Always assess functional impact on work, home activities, and interpersonal relationships alongside the score

The PHQ-4's brevity (4 items, <1 minute administration) makes it ideal for repeated screening in busy clinical settings, while maintaining robust psychometric properties comparable to longer instruments 3.